California State Teachers Retirement System (CalSTRS)’s Carisma Therapeutics CARM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,680
Closed -$6.08K 3105
2024
Q1
$6.08K Sell
2,680
-1,709
-39% -$4.11K ﹤0.01% 2985
2023
Q4
$12.9K Sell
4,389
-1,494
-25% -$4.44K ﹤0.01% 2974
2023
Q3
$24.9K Sell
5,883
-2,986
-34% -$18.9K ﹤0.01% 2942
2023
Q2
$77.8K Buy
+8,869
New +$48.3K ﹤0.01% 2737
2022
Q2
Sell
-4,382
Closed -$53K 3159
2022
Q1
$53K Sell
4,382
-728
-14% -$10.2K ﹤0.01% 3021
2021
Q4
$83K Buy
5,110
+512
+11% +$10.3K ﹤0.01% 3061
2021
Q3
$73K Sell
4,598
-7,196
-61% -$345K ﹤0.01% 3063
2021
Q2
$1.09M Buy
+11,794
New +$752K ﹤0.01% 2155
2015
Q2
Sell
-469
Closed -$84K 3005
2015
Q1
$84K Buy
469
+45
+11% +$9.83K ﹤0.01% 3000
2014
Q4
$101K Buy
424
+2
+0.5% +$449 ﹤0.01% 3008
2014
Q3
$94K Buy
422
+7
+2% +$1.66K ﹤0.01% 3001
2014
Q2
$109K Hold
415
﹤0.01% 2991
2014
Q1
$135K Buy
+415
New +$124K ﹤0.01% 2966

Other funds holding CARM

California State Teachers Retirement System (CalSTRS)'s CARM Position: Q2 2024 in Review

California State Teachers Retirement System (CalSTRS) sold out of Carisma Therapeutics (CARM) in Q2 2024, closing a stake of 2,680 shares — an estimated $6.08K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in CARM in Q1 2014 and held it in 13 quarters. The position peaked at $1.09M in Q2 2021. 53 funds tracked by Wall St. Rank hold CARM as of Q2 2024.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Carisma Therapeutics position as of Q2 2024 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 2,680 Carisma Therapeutics shares in Q2 2024, an estimated $6.08K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Carisma Therapeutics in Q1 2014 and held it in 13 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Carisma Therapeutics position peaked at $1.09M in Q2 2021.
  • 53 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q2 2024.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2024, filed 14 Aug 2024.